HK1062810A1 - Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease - Google Patents

Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease

Info

Publication number
HK1062810A1
HK1062810A1 HK04105655A HK04105655A HK1062810A1 HK 1062810 A1 HK1062810 A1 HK 1062810A1 HK 04105655 A HK04105655 A HK 04105655A HK 04105655 A HK04105655 A HK 04105655A HK 1062810 A1 HK1062810 A1 HK 1062810A1
Authority
HK
Hong Kong
Prior art keywords
heartdisease
medicaments
inhibitors
prevention
manufacture
Prior art date
Application number
HK04105655A
Other languages
English (en)
Inventor
Charles Dinarello
Benjamin Pomerantz
Leonid Reznikov
Alden Harken
Yolande Chvatchko
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of HK1062810A1 publication Critical patent/HK1062810A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK04105655A 2001-01-29 2004-08-02 Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease HK1062810A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01101959 2001-01-29
PCT/EP2002/000844 WO2002060479A1 (en) 2001-01-29 2002-01-28 Use of il-18 inhibitors for the treatment and/or prevention of heart disease

Publications (1)

Publication Number Publication Date
HK1062810A1 true HK1062810A1 (en) 2004-11-26

Family

ID=8176323

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04105655A HK1062810A1 (en) 2001-01-29 2004-08-02 Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease

Country Status (32)

Country Link
US (1) US20040234523A1 (xx)
EP (1) EP1355668B1 (xx)
JP (2) JP4860897B2 (xx)
KR (1) KR100857376B1 (xx)
CN (1) CN1326562C (xx)
AR (1) AR032422A1 (xx)
AT (1) ATE380558T1 (xx)
BG (1) BG66483B1 (xx)
BR (1) BR0206819A (xx)
CA (1) CA2435466C (xx)
CY (1) CY1107203T1 (xx)
CZ (1) CZ305653B6 (xx)
DE (1) DE60224004T2 (xx)
DK (1) DK1355668T3 (xx)
EA (2) EA006767B1 (xx)
EE (1) EE05534B1 (xx)
ES (1) ES2295332T3 (xx)
HK (1) HK1062810A1 (xx)
HR (1) HRP20030609A2 (xx)
HU (1) HU229164B1 (xx)
IL (2) IL157024A0 (xx)
ME (1) ME00549B (xx)
MX (1) MXPA03006776A (xx)
NO (1) NO331083B1 (xx)
PL (1) PL213568B1 (xx)
PT (1) PT1355668E (xx)
RS (1) RS51125B (xx)
SI (1) SI1355668T1 (xx)
SK (1) SK287620B6 (xx)
UA (1) UA80676C2 (xx)
WO (1) WO2002060479A1 (xx)
ZA (1) ZA200305439B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058956A2 (en) 2000-02-10 2001-08-16 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
EP2357002A1 (en) 2000-10-11 2011-08-17 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
SI1622939T1 (sl) 2003-05-13 2012-06-29 Merck Serono Sa Akrivne variante il-18 vezavnega proteina in medicinske uporabe le-tega
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
JP4961559B2 (ja) * 2004-03-11 2012-06-27 友昭 星野 インターロイキン１８阻害剤を有効成分とする疾患の予防又は治療剤
AU2006254103B2 (en) 2005-06-03 2012-09-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
RS52273B (en) 2005-06-10 2012-10-31 Ares Trading S.A. PROCESS FOR PURIFICATION OF IL-18 BINDING PROTEIN
JP5968590B2 (ja) * 2007-11-05 2016-08-10 ケーシーアイ ライセンシング インコーポレイテッド 創面切除のための組織の同定
JOP20200308A1 (ar) 2012-09-07 2017-06-16 Novartis Ag جزيئات إرتباط il-18
HUE055608T2 (hu) * 2013-09-05 2021-12-28 Ab2 Bio Sa IL-18-kötõ fehérje (IL-18BP) gyulladásos betegségekben
MX2017010919A (es) * 2015-03-05 2017-12-07 Ab2 Bio Sa Proteina de union il-18 (il-18bp) y anticuerpos en enfermedades inflamatorias.
WO2018013509A1 (en) * 2016-07-11 2018-01-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for diagnosing and treating arrhythmias

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5605690A (en) * 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
NZ322197A (en) * 1995-11-21 1999-02-25 Yamanouchi Pharma Co Ltd Pyrido[2,3-d] pyrimidine derivatives and pharmaceutical compositions thereof
WO1998010778A1 (en) * 1996-09-12 1998-03-19 Idun Pharmaceuticals, Inc. INHIBITION OF APOPTOSIS USING INTERLEUKIN-1β-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS
JP4094066B2 (ja) * 1996-12-06 2008-06-04 バーテックス ファーマシューティカルズ インコーポレイテッド インターロイキン−１β変換酵素のインヒビター
EP0998300A1 (en) * 1997-03-18 2000-05-10 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
DE19743687C1 (de) * 1997-10-06 1998-11-26 Henkel Kgaa Detergensgemische und deren Verwendung
AU4961499A (en) * 1998-06-26 2000-01-17 Eli Lilly And Company 5-HT1f agonists
KR100537558B1 (ko) * 1998-09-01 2005-12-19 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 인터류킨-18 결합 단백질
EP1022027A1 (en) * 1999-01-22 2000-07-26 Applied Research Systems ARS Holding N.V. Tumor necrosis factor antagonists and their use in endometriosis
DE60030097T2 (de) * 1999-03-16 2007-03-08 Cytovia, Inc., San Diego Substituierte 2-aminobenzamin caspase inhibitoren und ihre verwendung
DE60035037T2 (de) * 1999-04-09 2008-01-31 Cytovia, Inc., San Diego Caspase inhibitoren und ihre verwendung
AU6078500A (en) * 1999-07-09 2001-01-30 Amgen, Inc. Combination therapy for conditions leading to bone loss
WO2001058956A2 (en) * 2000-02-10 2001-08-16 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
UA87658C2 (uk) * 2000-05-05 2009-08-10 Апплайд Резеч Системз Арс Холдинг Н.В. Застосування il-18 як діагностичного маркера серцевої недостатності
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders

Also Published As

Publication number Publication date
ES2295332T3 (es) 2008-04-16
AR032422A1 (es) 2003-11-05
CY1107203T1 (el) 2012-11-21
BG66483B1 (bg) 2015-03-31
BG108128A (bg) 2004-11-30
KR20030070143A (ko) 2003-08-27
SK287620B6 (sk) 2011-04-05
DE60224004D1 (de) 2008-01-24
ATE380558T1 (de) 2007-12-15
PL213568B1 (pl) 2013-03-29
EP1355668B1 (en) 2007-12-12
KR100857376B1 (ko) 2008-09-05
ZA200305439B (en) 2004-07-15
BR0206819A (pt) 2004-02-03
NO20033228L (no) 2003-09-26
PL366802A1 (en) 2005-02-07
NO20033228D0 (no) 2003-07-16
IL157024A0 (en) 2004-02-08
YU57803A (sh) 2006-05-25
HRP20030609A2 (en) 2005-06-30
EP1355668A1 (en) 2003-10-29
CZ305653B6 (cs) 2016-01-27
JP2004522748A (ja) 2004-07-29
WO2002060479A1 (en) 2002-08-08
CA2435466A1 (en) 2002-08-08
NO331083B1 (no) 2011-10-03
IL157024A (en) 2014-02-27
CA2435466C (en) 2012-04-03
EA200501549A1 (ru) 2006-04-28
MXPA03006776A (es) 2003-10-24
JP2009102354A (ja) 2009-05-14
EE200300328A (et) 2003-10-15
US20040234523A1 (en) 2004-11-25
RS51125B (sr) 2010-10-31
EA006767B1 (ru) 2006-04-28
EA010180B1 (ru) 2008-06-30
SK10892003A3 (sk) 2004-02-03
JP4860897B2 (ja) 2012-01-25
DE60224004T2 (de) 2009-07-23
UA80676C2 (en) 2007-10-25
PT1355668E (pt) 2008-01-04
CN1326562C (zh) 2007-07-18
SI1355668T1 (sl) 2008-06-30
ME00549B (me) 2011-10-10
EA200300844A1 (ru) 2003-12-25
HU229164B1 (en) 2013-09-30
EE05534B1 (et) 2012-04-16
CZ20032335A3 (en) 2004-07-14
HUP0303306A3 (en) 2005-12-28
DK1355668T3 (da) 2008-05-05
CN1499982A (zh) 2004-05-26
HUP0303306A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
SI1487541T1 (sl) Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja
HK1094909A1 (en) Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis il-18
AU2002339157A1 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
IL160187A0 (en) Aerosolized decongestants for the treatment of sinusitis
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
PL366636A1 (en) Pyranoindazoles and their use for the treatment of glaucoma
EP1461024A4 (en) TREATMENT OF WOUNDS AND COMPOSITIONS USED
SI1627639T1 (sl) Uporaba inhibitorjev COX-2 za zdravljenje afektivnih motenj
AU2003291480A8 (en) Composition for the prevention and treatment of inflammation of the ear
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
HK1062810A1 (en) Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GB0119025D0 (en) Compounds and their therapeutic use
HK1069762A1 (en) Use of il-18 inhibitors for treating or preventingcns injuries
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
EP1457210A4 (en) THERAPEUTIC AND / OR PROPHYLACTIC AGENTS FOR CONFORMATIONAL DISEASES
EP1557169A4 (en) THERAPEUTIC AND / OR PROPHYLACTIC AGENT FOR DYSCHEZIA
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
SI1610785T1 (sl) Farmacevtski kombiniran pripravek za zdravljenje spastiäśnosti in/ali boleäśine
SI1569929T1 (sl) Spojine in postopki za zdravljenje ali preprečevanje flavivirusnih infekcij
HU0105291D0 (en) Pharmaceutical compositions for the treatment of indigestion and related diseases
SI1392292T1 (sl) Piranoindazoli in njihova uporaba pri zdravljenjuglavkoma

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20220203